EC looks at phasing in new "black symbol" requirement
This article was originally published in SRA
Executive Summary
The European Commission is looking at whether phasing-in arrangements will be needed for the black symbol to be included on all medicines subject to additional monitoring to give companies enough time to make the necessary changes to their product labelling1.